Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.
KMID : 0371320100790030196
Journal of the Korean Surgical Society
2010 Volume.79 No. 3 p.196 ~ p.201
Resection A Surgery: An Exclusion Criterion of Adjuvant Treatment for Gastric Cancer
Yu Wan-Sik

Chung Ho-Young
Abstract
Purpose: We evaluated the clinical implication of Resection A surgery retrospectively to identify whether quality of surgery can be used as a selection factor for adjuvant therapy in patients with gastric cancer.

Methods: Prognosis of 902 patients with gastric cancer who underwent Resection A surgery was evaluated.

Results: Among all discharged patients, 77 patients (8.5%) died of recurrent disease, 55 patients (6.1%) died without recurrent disease. Five-year survival rate of all discharged patients was 91.6% and 10-year survival rate 87.1%. Statistically significant prognostic factors were depth of invasion (P£¼0.001), lymph node metastasis (P£¼ 0.001), stage (P£¼0.001), tumor location (P=0.036) and size (P=0.001), extent of gastric resection (P£¼0.001), and chemotherapy (P£¼0.001) on univariate analyses. However, depth of invasion (P=0.001), lymph node metastasis (P£¼0.001), and total gastrectomy (P£¼0.001) emerged as statistically significant poor prognostic factor on a multivariate analysis. Adjuvant chemotherapy did not increase the survival rate of patients after Resection A surgery, even in patients with stage II disease.

Conclusion: In selecting the patients for adjuvant therapy, both the stage of gastric cancer and the quality of surgery should be considered.
KEYWORD
Stomach neoplasm, Quality of surgery, Adjuvant chemotherapy
FullTexts / Linksout information
 
Listed journal information
ÇмúÁøÈïÀç´Ü(KCI) KoreaMed ´ëÇÑÀÇÇÐȸ ȸ¿ø